Click for best price
Immune Cell Therapy Market Size, Share 2023
This report contains market size and forecasts of Immune Cell Therapy in Global, including the following market information:
Global Immune Cell Therapy Market Size 2024-2032, ($ millions)
The global Immune Cell Therapy market is projected to reach US$ million by 2032.
We surveyed the Immune Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Cell Therapy Market, by Type, 2024-2032 ($ millions)
Global Immune Cell Therapy Market Segment Percentages, by Type
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other
Global Immune Cell Therapy Market, by Application, 2024-2032 ($ millions)
Global Immune Cell Therapy Market Segment Percentages, by Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
Global Immune Cell Therapy Market, By Region and Country, 2024-2032 ($ Millions)
Global Immune Cell Therapy Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
| Report Attributes |
Report Details |
| Report Title |
Immune Cell Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immune Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Cell Therapy Overall Market Size
2.1 Global Immune Cell Therapy Market Size: 2023 VS 2032
2.2 Global Immune Cell Therapy Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Immune Cell Therapy Players in Global Market
3.2 Global Companies Immune Cell Therapy Product & Technology
4 Immune Cell Therapy Companies Profiles
4.1 Adaptimmune
4.1.1 Adaptimmune Company Summary
4.1.2 Adaptimmune Business Overview
4.1.3 Adaptimmune Immune Cell Therapy Product Offerings & Technology
4.1.4 Adaptimmune Immune Cell Therapy R&D, and Plans
4.2 Altor Bioscience Corporation
4.2.1 Altor Bioscience Corporation Company Summary
4.2.2 Altor Bioscience Corporation Business Overview
4.2.3 Altor Bioscience Corporation Immune Cell Therapy Product Offerings & Technology
4.2.4 Altor Bioscience Corporation Immune Cell Therapy R&D, and Plans
4.3 Cellectis
4.3.1 Cellectis Company Summary
4.3.2 Cellectis Business Overview
4.3.3 Cellectis Immune Cell Therapy Product Offerings & Technology
4.3.4 Cellectis Immune Cell Therapy R&D, and Plans
4.4 Juno Therapeutics
4.4.1 Juno Therapeutics Company Summary
4.4.2 Juno Therapeutics Business Overview
4.4.3 Juno Therapeutics Immune Cell Therapy Product Offerings & Technology
4.4.4 Juno Therapeutics Immune Cell Therapy R&D, and Plans
4.5 Kite Pharma
4.5.1 Kite Pharma Company Summary
4.5.2 Kite Pharma Business Overview
4.5.3 Kite Pharma Immune Cell Therapy Product Offerings & Technology
4.5.4 Kite Pharma Immune Cell Therapy R&D, and Plans
4.6 Novartis
4.6.1 Novartis Company Summary
4.6.2 Novartis Business Overview
4.6.3 Novartis Immune Cell Therapy Product Offerings & Technology
4.6.4 Novartis Immune Cell Therapy R&D, and Plans
4.7 Takara Bio
4.7.1 Takara Bio Company Summary
4.7.2 Takara Bio Business Overview
4.7.3 Takara Bio Immune Cell Therapy Product Offerings & Technology
4.7.4 Takara Bio Immune Cell Therapy R&D, and Plans
4.8 Unum Therapeutics
4.8.1 Unum Therapeutics Company Summary
4.8.2 Unum Therapeutics Business Overview
4.8.3 Unum Therapeutics Immune Cell Therapy Product Offerings & Technology
4.8.4 Unum Therapeutics Immune Cell Therapy R&D, and Plans
5 Sights by Region
5.1 By Region - Global Immune Cell Therapy Market Size, 2024 & 2032
5.2 By Region - Global Immune Cell Therapy Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of Immune Cell Therapy in United States
5.3.2 United States Immune Cell Therapy Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Immune Cell Therapy in Europe
5.4.2 Europe Immune Cell Therapy Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Immune Cell Therapy in China
5.5.2 China Immune Cell Therapy Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Immune Cell Therapy Market Size Markets, 2024 & 2032
6.2 T Cell Therapy
6.3 Natural Killer (NK) Cell Therapy
6.4 Other
7 Sights by Application
7.1 By Application - Global Immune Cell Therapy Market Size, 2024 & 2032
7.2 Stomach Cancer
7.3 Lung Cancer
7.4 Colorectal Cancer
7.5 Esophageal Cancer
7.6 Pancreatic Cancer
7.7 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immune Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Immune Cell Therapy Market Drivers in Global Market
Table 3. Immune Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Immune Cell Therapy in Global Market
Table 5. Global Companies Immune Cell Therapy Product & Technology
Table 6. Adaptimmune Company Summary
Table 7. Adaptimmune Immune Cell Therapy Product Offerings
Table 8. Altor Bioscience Corporation Company Summary
Table 9. Altor Bioscience Corporation Immune Cell Therapy Product Offerings
Table 10. Cellectis Company Summary
Table 11. Cellectis Immune Cell Therapy Product Offerings
Table 12. Juno Therapeutics Company Summary
Table 13. Juno Therapeutics Immune Cell Therapy Product Offerings
Table 14. Kite Pharma Company Summary
Table 15. Kite Pharma Immune Cell Therapy Product Offerings
Table 16. Novartis Company Summary
Table 17. Novartis Immune Cell Therapy Product Offerings
Table 18. Takara Bio Company Summary
Table 19. Takara Bio Immune Cell Therapy Product Offerings
Table 20. Unum Therapeutics Company Summary
Table 21. Unum Therapeutics Immune Cell Therapy Product Offerings
Table 22. By Region? Global Immune Cell Therapy Revenue, (US$, Mn), 2024 & 2032
Table 23. By Region - Global Immune Cell Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Type ? Global Immune Cell Therapy Market Size, (US$, Mn), 2024 & 2032
Table 25. By Application? Global Immune Cell Therapy Market Size, (US$, Mn), 2024 & 2032
List of Figures
Figure 1. Immune Cell Therapy Segment by Type in 2032
Figure 2. Immune Cell Therapy Segment by Application in 2032
Figure 3. Global Immune Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immune Cell Therapy Market Size: 2023 VS 2032 (US$, Mn)
Figure 6. Global Immune Cell Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Immune Cell Therapy Revenue Market Share, 2024-2032
Figure 8. By Type - Global Immune Cell Therapy Revenue Market Share, 2024-2032
Figure 9. By Application - Global Immune Cell Therapy Revenue Market Share, 2024-2032
